DCF — FAIRCHILD MEDICAL CENTER
Enterprise Value: $-26.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-26.6M
Enterprise Value
$-11.4M
PV of Cash Flows
$-15.2M
PV of Terminal Value
$-24.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $112.7M | $0.2M | 0.0% | $-4.6M | $-4.2M |
| Year 2 | $116.1M | $1.4M | 1.0% | $-3.5M | $-2.9M |
| Year 3 | $119.6M | $2.6M | 2.0% | $-2.5M | $-1.8M |
| Year 4 | $123.2M | $3.3M | 3.0% | $-2.0M | $-1.3M |
| Year 5 | $126.9M | $3.7M | 3.0% | $-1.8M | $-1.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-26.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$109.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0032239599015514916
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5